Tetra in manufacturing deal for printed CBD treatment

By Ben Hargreaves contact

- Last updated on GMT


Related tags: CBD, 2D Printing, THC

Tetra Bio-Pharma signs agreement for the commercial manufacture of two CBD-based drug candidates.

The deal will significantly increase the scale of production of both Caumz (synthetic tetrahydrocannabinol (THC) and cannabidiol (CBD)) and HCC011 (inhaled delta-9-THC) – with production capacity increased from 2,500 dosing capsules in a three-day period to 100,000 dosage units in a single eight-hour period.

In addition, the products will receive four additional manufacturing patents related to the production method.

The partnership sees Vitiprints, a specialist in 2D printing technology, provide Tetra Bio-Pharma with an exclusive license to use the technology for the commercial production of its two drug candidates, for use within a vaporizing system, Caumz-kit.

In exchange for the license to use the technology, Vitiprints will receive undisclosed milestone and royalty payments based on potential sales of the Caumz product.

Vitiprints will visit Tetra’s manufacturing site in Moncton, Canada, with the aim of introducing its technology to the site during the spring of this year, the company stated.

Guy Chamberland, Tetra’s CEO, noted that once this has been implemented, a further scale-up and transfer will take place in its Greater Montreal facility.

The company added that this method of manufacture will reduce cost of goods sold by 75%.

Caumz is currently at the Phase II trial stage for the treatment of both advanced cancer pain and breakthrough pain, while HCC011 is being investigated at the same stage for hepatocellular carcinoma.

In the latter indication, Tetra is exploring HCC011 to improve quality of life for cancer patients, as well as exploring potential antitumor activity.

Based on consultation with the US Food and Drug Administration (FDA), Tetra will apply for approval through fast track designation and accelerated approval for Caumz.


Related news

Show more

Related products

show more

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us


View more